{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:58:47Z","timestamp":1793145527267,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00774-020-01132-y","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T20:05:50Z","timestamp":1596139550000},"page":"772-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Role of the renin\u2013angiotensin\u2013aldosterone system in bone metabolism"],"prefix":"10.1007","volume":"38","author":[{"given":"Caiyan","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"1132_CR1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"VS Chhokar","year":"2005","unstructured":"Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT (2005) Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111:871\u2013878","journal-title":"Circulation"},{"key":"1132_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00198-015-3348-y","volume":"27","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wang L, Song Y, Zhao X, Wong MS, Zhang W (2016) Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice. Osteoporos Int 27:1083\u20131092","journal-title":"Osteoporos Int"},{"key":"1132_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bone.2017.01.029","volume":"97","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Li XL, Sha NN, Shu B, Zhao YJ, Wang XL, Xiao HH, Shi Q, Wong MS, Wang YJ (2017) Differential response of bone and kidney to ACEI in db\/db mice: A potential effect of captopril on accelerating bone loss. Bone 97:222\u2013232","journal-title":"Bone"},{"key":"1132_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1357-2725(02)00306-0","volume":"35","author":"MJ McKinley","year":"2003","unstructured":"McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA, Chai SY (2003) The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 35:901\u2013918","journal-title":"Int J Biochem Cell Biol"},{"key":"1132_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1470320314549791","volume":"16","author":"AJ White","year":"2015","unstructured":"White AJ, Cheruvu SC, Sarris M, Liyanage SS, Lumbers E, Chui J, Wakefield D, McCluskey PJ (2015) Expression of classical components of the renin-angiotensin system in the human eye. J Renin Angiotensin Aldosterone Syst 16:59\u201366","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1132_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.113.01910","volume":"63","author":"JM Brown","year":"2014","unstructured":"Brown JM, Williams JS, Luther JM, Garg R, Garza AE, Pojoga LH, Ruan DT, Williams GH, Adler GK, Vaidya A (2014) Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension 63:273\u2013280","journal-title":"Hypertension"},{"key":"1132_CR7","doi-asserted-by":"publisher","first-page":"115041","DOI":"10.1016\/j.bone.2019.115041","volume":"128","author":"CM Queiroz-Junior","year":"2019","unstructured":"Queiroz-Junior CM, Santos A, Galvao I, Souto GR, Mesquita RA, Sa MA, Ferreira AJ (2019) The angiotensin converting enzyme 2\/angiotensin-(1\u20137)\/Mas Receptor axis as a key player in alveolar bone remodeling. Bone 128:115041","journal-title":"Bone"},{"key":"1132_CR8","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","volume":"159","author":"P Garcia","year":"2010","unstructured":"Garcia P, Schwenzer S, Slotta JE, Scheuer C, Tami AE, Holstein JH, Histing T, Burkhardt M, Pohlemann T, Menger MD (2010) Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation - role of a local renin-angiotensin system. Br J Pharmacol 159:1672\u20131680","journal-title":"Br J Pharmacol"},{"key":"1132_CR9","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.3390\/ijms12074206","volume":"12","author":"XX Guan","year":"2011","unstructured":"Guan XX, Zhou Y, Li JY (2011) Reciprocal roles of angiotensin II and Angiotensin II Receptors Blockade (ARB) in regulating Cbfa1\/RANKL via cAMP signaling pathway: possible mechanism for hypertension-related osteoporosis and antagonistic effect of ARB on hypertension-related osteoporosis. Int J Mol Sci 12:4206\u20134213","journal-title":"Int J Mol Sci"},{"key":"1132_CR10","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","volume":"16","author":"S Beavan","year":"2001","unstructured":"Beavan S, Horner A, Bord S, Ireland D, Compston J (2001) Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J Bone Miner Res 16:1496\u20131504","journal-title":"J Bone Miner Res"},{"key":"1132_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/HYPERTENSIONAHA.112.195891","volume":"60","author":"GP Rossi","year":"2012","unstructured":"Rossi GP, Ragazzo F, Seccia TM, Maniero C, Barisa M, Calo LA, Frigo AC, Fassina A, Pessina AC (2012) Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. Hypertension 60:431\u2013436","journal-title":"Hypertension"},{"key":"1132_CR12","doi-asserted-by":"publisher","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","volume":"280","author":"G Mazzocchi","year":"2001","unstructured":"Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG (2001) PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells. Am J Physiol Endocrinol Metab 280:E209\u2013E213","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1132_CR13","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","volume":"119","author":"E Hagstrom","year":"2009","unstructured":"Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K, Arnlov J (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765\u20132771","journal-title":"Circulation"},{"key":"1132_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0026-0495(99)90075-6","volume":"48","author":"G Bernini","year":"1999","unstructured":"Bernini G, Moretti A, Lonzi S, Bendinelli C, Miccoli P, Salvetti A (1999) Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery. Metabolism 48:298\u2013300","journal-title":"Metabolism"},{"key":"1132_CR15","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3892\/etm.2017.4404","volume":"13","author":"L Shen","year":"2017","unstructured":"Shen L, Ma C, Shuai B, Yang Y (2017) Effects of 1,25-dihydroxyvitamin D3 on the local bone renin-angiotensin system in a murine model of glucocorticoid-induced osteoporosis. Exp Ther Med 13:3297\u20133304","journal-title":"Exp Ther Med"},{"key":"1132_CR16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1681\/ASN.2009080872","volume":"21","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Kong J, Deb DK, Chang A, Li YC (2010) Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol 21:966\u2013973","journal-title":"J Am Soc Nephrol"},{"key":"1132_CR17","doi-asserted-by":"publisher","first-page":"836529","DOI":"10.1155\/2014\/836529","volume":"2014","author":"L Petramala","year":"2014","unstructured":"Petramala L, Zinnamosca L, Settevendemmie A, Marinelli C, Nardi M, Concistre A, Corpaci F, Tonnarini G, De Toma G, Letizia C (2014) Bone and mineral metabolism in patients with primary aldosteronism. Int J Endocrinol 2014:836529","journal-title":"Int J Endocrinol"},{"key":"1132_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/cen.14177","volume":"92","author":"NA Ismail","year":"2020","unstructured":"Ismail NA, Kamaruddin NA, Azhar Shah S, Sukor N (2020) The effect of vitamin D treatment on clinical and biochemical outcomes of primary aldosteronism. Clin Endocrinol (Oxf) 92:509\u2013517","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1132_CR19","first-page":"1672","volume":"173","author":"MD Witham","year":"2013","unstructured":"Witham MD, Price RJ, Struthers AD, Donnan PT, Messow CM, Ford I, McMurdo ME (2013) Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 173:1672\u20131679","journal-title":"JAMA Intern Med"},{"key":"1132_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","volume":"46","author":"PH Law","year":"2005","unstructured":"Law PH, Sun Y, Bhattacharya SK, Chhokar VS, Weber KT (2005) Diuretics and bone loss in rats with aldosteronism. J Am Coll Cardiol 46:142\u2013146","journal-title":"J Am Coll Cardiol"},{"key":"1132_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","volume":"58","author":"C Maniero","year":"2011","unstructured":"Maniero C, Fassina A, Guzzardo V, Lenzini L, Amadori G, Pelizzo MR, Gomez-Sanchez C, Rossi GP (2011) Primary hyperparathyroidism with concurrent primary aldosteronism. Hypertension 58:341\u2013346","journal-title":"Hypertension"},{"key":"1132_CR22","doi-asserted-by":"publisher","first-page":"H2023","DOI":"10.1152\/ajpheart.00477.2004","volume":"287","author":"VS Chhokar","year":"2004","unstructured":"Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT (2004) Loss of bone minerals and strength in rats with aldosteronism. Am J Physiol Heart Circ Physiol 287:H2023\u2013H2026","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1132_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/hr.2010.159","volume":"33","author":"AA Zia","year":"2010","unstructured":"Zia AA, Kamalov G, Newman KP, McGee JE, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT (2010) From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation (in eng). Hypertens Res 33:1091\u20131101","journal-title":"Hypertens Res"},{"key":"1132_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1210\/jc.2016-3206","volume":"102","author":"M Notsu","year":"2017","unstructured":"Notsu M, Yamauchi M, Yamamoto M, Nawata K, Sugimoto T (2017) Primary aldosteronism as a risk factor for vertebral fracture. J Clin Endocrinol Metab 102:1237\u20131243","journal-title":"J Clin Endocrinol Metab"},{"key":"1132_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2018.11.003","volume":"363","author":"Y Wen","year":"2019","unstructured":"Wen Y, Shangguan Y, Pan Z, Hu H, Magdalou J, Chen L, Wang H (2019) Activation of local bone RAS by maternal excessive glucocorticoid participated in the fetal programing of adult osteopenia induced by prenatal caffeine exposure. Toxicol Appl Pharmacol 363:1\u201310","journal-title":"Toxicol Appl Pharmacol"},{"key":"1132_CR26","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1271\/bbb.120123","volume":"76","author":"SS Gu","year":"2012","unstructured":"Gu SS, Zhang Y, Li XL, Wu SY, Diao TY, Hai R, Deng HW (2012) Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice. Biosci Biotechnol Biochem 76:1367\u20131371","journal-title":"Biosci Biotechnol Biochem"},{"key":"1132_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/HYPERTENSIONAHA.115.06837","volume":"67","author":"AL Kuipers","year":"2016","unstructured":"Kuipers AL, Kammerer CM, Pratt JH, Bunker CH, Wheeler VW, Patrick AL, Zmuda JM (2016) Association of circulating renin and aldosterone with osteocalcin and bone mineral density in african ancestry families. Hypertension 67:977\u2013982","journal-title":"Hypertension"},{"key":"1132_CR28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00198-014-2992-y","volume":"26","author":"B Shuai","year":"2015","unstructured":"Shuai B, Yang YP, Shen L, Zhu R, Xu XJ, Ma C, Lv L, Zhao J, Rong JH (2015) Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients. Osteoporos Int 26:1063\u20131071","journal-title":"Osteoporos Int"},{"key":"1132_CR29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3389\/fphar.2019.00708","volume":"10","author":"SHP Oliveira","year":"2019","unstructured":"Oliveira SHP, Brito VGB, Frasnelli SCT, Ribeiro BDS, Ferreira MN, Queiroz DP, Beltan CT, Lara VS, Santos CF (2019) Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease. Front Pharmacol 10:708","journal-title":"Front Pharmacol"},{"key":"1132_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.pharep.2018.02.008","volume":"70","author":"XF Chen","year":"2018","unstructured":"Chen XF, Li XL, Liu JX, Xu J, Zhao YY, Yang M, Zhang Y (2018) Inhibition on angiotensin-converting enzyme exerts beneficial effects on trabecular bone in orchidectomized mice. Pharmacol Rep 70:705\u2013711","journal-title":"Pharmacol Rep"},{"key":"1132_CR31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/hr.2009.99","volume":"32","author":"H Shimizu","year":"2009","unstructured":"Shimizu H, Nakagami H, Osako MK, Nakagami F, Kunugiza Y, Tomita T, Yoshikawa H, Rakugi H, Ogihara T, Morishita R (2009) Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats. Hypertens Res 32:786\u2013790","journal-title":"Hypertens Res"},{"key":"1132_CR32","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22:2465\u20132475","journal-title":"FASEB J"},{"key":"1132_CR33","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.lfs.2018.04.042","volume":"205","author":"YZ Cheng","year":"2018","unstructured":"Cheng YZ, Yang SL, Wang JY, Ye M, Zhuo XY, Wang LT, Chen H, Zhang H, Yang L (2018) Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs\/RAGE pathway. Life Sci 205:184\u2013192","journal-title":"Life Sci"},{"key":"1132_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","volume":"447","author":"T Fumoto","year":"2014","unstructured":"Fumoto T, Ishii KA, Ito M, Berger S, Schutz G, Ikeda K (2014) Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochem Biophys Res Commun 447:407\u2013412","journal-title":"Biochem Biophys Res Commun"},{"key":"1132_CR35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/HJH.0b013e32834f6b43","volume":"30","author":"M Boschmann","year":"2012","unstructured":"Boschmann M, Nussberger J, Engeli S, Danser AH, Yeh CM, Prescott MF, Dahlke M, Jordan J (2012) Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patients. J Hypertens 30:561\u2013566","journal-title":"J Hypertens"},{"key":"1132_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11657-017-0387-3","volume":"12","author":"N Rianon","year":"2017","unstructured":"Rianon N, Ambrose CG, Pervin H, Garcia M, Mama SK, Schwartz AV, Lee B, Harris T (2017) Long-term use of angiotensin-converting enzyme inhibitors protects against bone loss in African-American elderly men. Arch Osteoporos 12:94","journal-title":"Arch Osteoporos"},{"key":"1132_CR37","doi-asserted-by":"crossref","unstructured":"Garcia-Testal A, Monzo A, Rabanaque G, Gonzalez A, Romeu A (2006) [Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril] (in spa). Med Clin (Barc) (Evolucion de la densidad osea de mujeres menopausicas hipertensas en tratamiento con fosinopril.) 127:692\u2013694","DOI":"10.1157\/13095095"},{"key":"1132_CR38","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/ggi.12406","volume":"15","author":"M Aoki","year":"2015","unstructured":"Aoki M, Kawahata H, Sotobayashi D, Yu H, Moriguchi A, Nakagami H, Ogihara T, Morishita R (2015) Effect of angiotensin II receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome. Geriatr Gerontol Int 15:1064\u20131072","journal-title":"Geriatr Gerontol Int"},{"key":"1132_CR39","first-page":"57","volume":"46","author":"T Kwok","year":"2017","unstructured":"Kwok T, Leung J, Barrett-Connor E (2017) ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men. Age Ageing 46:57\u201364","journal-title":"Age Ageing"},{"key":"1132_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jacc.2008.03.039","volume":"52","author":"LD Carbone","year":"2008","unstructured":"Carbone LD, Cross JD, Raza SH, Bush AJ, Sepanski RJ et al (2008) Fracture risk in men with congestive heart failure risk reduction with spironolactone. J Am Coll Cardiol 52:135\u2013138","journal-title":"J Am Coll Cardiol"},{"key":"1132_CR41","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/jbmr.1660","volume":"27","author":"AS Salcuni","year":"2012","unstructured":"Salcuni AS, Palmieri S, Carnevale V, Morelli V, Battista C, Guarnieri V, Guglielmi G, Desina G, Eller-Vainicher C, Beck-Peccoz P, Scillitani A, Chiodini I (2012) Bone involvement in aldosteronism. J Bone Miner Res 27:2217\u20132222","journal-title":"J Bone Miner Res"},{"key":"1132_CR42","doi-asserted-by":"publisher","first-page":"628","DOI":"10.5114\/aoms.2015.52369","volume":"11","author":"K Nakai","year":"2015","unstructured":"Nakai K, Kawato T, Morita T, Yamazaki Y, Tanaka H, Tonogi M, Oki H, Maeno M (2015) Angiotensin II suppresses osteoblastic differentiation and mineralized nodule formation via AT1 receptor in ROS17\/2.8 cells. Arch Med Sci 11:628\u2013637","journal-title":"Arch Med Sci"},{"key":"1132_CR43","doi-asserted-by":"crossref","unstructured":"Mulinari-Santos G, de Souza Batista FR, Kirchweger F, Tangl S, Gruber R, Okamoto R (2018) Losartan reverses impaired osseointegration in spontaneously hypertensive rats (in eng). Clin Oral Implants Res","DOI":"10.1111\/clr.123_13358"},{"key":"1132_CR44","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jdiacomp.2016.08.016","volume":"30","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wang L, Liu JX, Wang XL, Shi Q, Wang YJ (2016) Involvement of skeletal renin-angiotensin system and kallikrein-kinin system in bone deteriorations of type 1 diabetic mice with estrogen deficiency. J Diabetes Complications 30:1419\u20131425","journal-title":"J Diabetes Complications"},{"key":"1132_CR45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s12020-014-0196-z","volume":"47","author":"Z Yongtao","year":"2014","unstructured":"Yongtao Z, Kunzheng W, Jingjing Z, Hu S, Jianqiang K, Ruiyu L, Chunsheng W (2014) Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis. Endocrine 47:598\u2013608","journal-title":"Endocrine"},{"key":"1132_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.biopha.2017.05.062","volume":"92","author":"HM Abuohashish","year":"2017","unstructured":"Abuohashish HM, Ahmed MM, Sabry D, Khattab MM, Al-Rejaie SS (2017) ACE-2\/Ang1-7\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats. Biomed Pharmacother 92:58\u201368","journal-title":"Biomed Pharmacother"},{"key":"1132_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00774-013-0500-7","volume":"32","author":"TY Diao","year":"2014","unstructured":"Diao TY, Pan H, Gu SS, Chen X, Zhang FY, Wong MS, Zhang Y (2014) Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes. J Bone Miner Metab 32:261\u2013270","journal-title":"J Bone Miner Metab"},{"key":"1132_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2015.01.072","volume":"184","author":"HJ Choi","year":"2015","unstructured":"Choi HJ, Park C, Lee YK, Ha YC, Jang S, Shin CS (2015) Risk of fractures in subjects with antihypertensive medications: a nationwide claim study. Int J Cardiol 184:62\u201367","journal-title":"Int J Cardiol"},{"key":"1132_CR49","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jbmr.3033","volume":"32","author":"VC Wu","year":"2017","unstructured":"Wu VC, Chang CH, Wang CY, Lin YH, Kao TW, Lin PC, Chu TS, Chang YS, Chen L, Wu KD, Chueh SJ (2017) Risk of fracture in primary aldosteronism: a population-based cohort study. J Bone Miner Res 32:743\u2013752","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-020-01132-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T20:36:18Z","timestamp":1650227778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-020-01132-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1007\/s00774-020-01132-y","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]},"assertion":[{"value":"11 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this correspondence informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}